163 related articles for article (PubMed ID: 11462974)
1. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
Bioorg Med Chem; 1999 Jun; 7(6):1033-41. PubMed ID: 10428371
[TBL] [Abstract][Full Text] [Related]
5. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500
[TBL] [Abstract][Full Text] [Related]
6. Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: evidence for a cyclic bioactive conformation.
Matsoukas J; Hollenberg MD; Mavromoustakos T; Panagiotopoulos D; Alexopoulos K; Yamdagni R; Wu Q; Moore GJ
J Protein Chem; 1997 Feb; 16(2):113-31. PubMed ID: 9112605
[TBL] [Abstract][Full Text] [Related]
7. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
[TBL] [Abstract][Full Text] [Related]
8. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
Pletneva EV; Laederach AT; Fulton DB; Kostic NM
J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
[TBL] [Abstract][Full Text] [Related]
10. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
14. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
[TBL] [Abstract][Full Text] [Related]
15. Conformation and complexation with metal ions of cyclic hexapeptides: cyclo (L-Leu-L-Phe-L-Pro)2 and cyclo [L-Cys(Acm)-L-Phe-L-Pro]2.
Ozeki E; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):111-7. PubMed ID: 2807727
[TBL] [Abstract][Full Text] [Related]
16. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
[TBL] [Abstract][Full Text] [Related]
17. The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.
Siahaan TJ; Bruss D; Powell NA; Chakrabarti S; Conrad M
Int J Pept Protein Res; 1994 Nov; 44(5):427-34. PubMed ID: 7896500
[TBL] [Abstract][Full Text] [Related]
18. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
Ni F; Meinwald YC; Vásquez M; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
[TBL] [Abstract][Full Text] [Related]
19. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.
Laniyonu AA; Hollenberg MD
Br J Pharmacol; 1995 Apr; 114(8):1680-6. PubMed ID: 7541284
[TBL] [Abstract][Full Text] [Related]
20. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
